Oceania · Regional markets · The Motley Fool Australia

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

Published by The Motley Fool Australia · Australia 2 h ago

Telix Pharmaceuticals' Q3 2026 update sees strong revenue growth, FDA milestones, and a major merger to expand its radiopharmaceuticals platform. The post Telix Pharmaceuticals Q3…

Read the full article on The Motley Fool Australia Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com.au)

Also worth reading

Business News (WA)

Mino Founder Mel Moss On How Her Son’s Sleep Problems Led To A New Bedding Business

Market Index

Morning Wrap: ASX 200 to rise, Dow rallies on defensive pivot, S&P 500 gains on oil retreat

SmartCompany

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

Share

Also worth reading

Woodside confirms plan to sell down $3.3b project after two years of ownership

GAMING: 6 of the best indie games from the PAX Australia show floor

Transport costs to Sydney's new airport: Is it worth it for you?

Mino Founder Mel Moss On How Her Son’s Sleep Problems Led To A New Bedding Business

Morning Wrap: ASX 200 to rise, Dow rallies on defensive pivot, S&P 500 gains on oil retreat

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail